NCT01815073View on ClinicalTrials.gov

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

497

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Japanese EncephalitisChickenpox
Interventions
BIOLOGICAL

Live Attenuated Varicella Vaccine + Live Attenuated JE Vaccine

BIOLOGICAL

Live Attenuated Varicella Vaccine

BIOLOGICAL

live attenuated JE vaccine

Trial Locations (1)

Unknown

Guangzhou Haizhu District Center for Disease Control and Prevention, Guangzhou

All Listed Sponsors
collaborator

Guangdong Provincial Institute of Biological Products And Materia Medica

OTHER

lead

Changchun Keygen Biological Products Co., Ltd.

OTHER

NCT01815073 - Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine | Biotech Hunter | Biotech Hunter